Gravity Analytica

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 10, 2025

MEDP 01.02.2025

SERA-AI Powered Highlights

Date of Upcoming Event:2025-02-11

Name of Upcoming Event:Conference Call

Full Press Release SEC Filings Our MEDP Tweets

About Gravity Analytica

Recent Filings

CINCINNATI--(BUSINESS WIRE)--Jan. 2, 2025--Medpace Holdings, Inc.(Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2024 financial results after the market close onMonday, February 10, 2025. The Company will host a conference call the following morning,Tuesday, February 11, 2025, at9:00 a.m. ETto discuss these results.

To participate in the conference call, interested parties must register in advance by clicking onthis link. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call.

To access the conference call via webcast, visit the “Investors” section of Medpace’s website atinvestor.medpace.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.

AboutMedpace

Medpaceis a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered inCincinnati, Ohio,Medpaceemploys approximately 5,900 people across 43 countries as ofSeptember 30, 2024.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20250102726843/en/

Investor Contact:Lauren Morris513.579.9911 x11994l.morris@medpace.com

Media Contact:Michael Maley513.579.9911 x12831m.maley@medpace.com

Source:Medpace Holdings, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com